Skip to main content

Advertisement

SpringerLink
Log in

TACI, isotype switching, CVID and IgAD

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Common Variable Immunodeficiency (CVID) is the most prevalent human primary immunodeficiency requiring medical attention. Until recently the only known genetic defect specific to CVID was ICOS deficiency that accounts for about 1% of the patients analyzed. Mutations in the TNFR family member TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor), which mediates isotype switching in B cells, were found to be present in 5% of patients with CVID. Mutations in TACI were also found in relatives of patients with CVID who suffered from IgA deficiency (IgAD) as well as in a patient with isolated IgAD. In the majority of patients described to date only one TACI allele is mutated, showing an autosomal dominant transmission of the disease. B cells from individuals with TACI mutations did not produce IgG and IgA in response to the TACI ligand, APRIL (a proliferation-inducing ligand), probably reflecting impaired isotype switching. These results suggest that TACI mutations can lead to CVID.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mackay F, Kalled SL. TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol 2002;14:783–90.

    Article  PubMed  CAS  Google Scholar 

  2. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003;21:231–64.

    Article  PubMed  CAS  Google Scholar 

  3. Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ. Selective activation of TACI by syndecan-2. Blood 2006;107:3235–42.

    Article  PubMed  CAS  Google Scholar 

  4. Hendriks J, Planelles L, de Jong-Odding J, Hardenberg G, Pals S, Hahne M, Spaargaren M, Medema J. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005;12:637–48.

    Article  PubMed  CAS  Google Scholar 

  5. Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner Q, Cachero T, Qiang F, Gorelik L, Kalled S, Acha-Orbea H, Rennert P, Tschopp J, Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 2005;201:1375–83.

    Article  PubMed  CAS  Google Scholar 

  6. Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, Kaukel P, Pantesco V, De Vos J, Jourdan E, Jauch A, Legouffe E, Moos M, Fiol G, Goldschmidt H, Rossi JF, Hose D, Klein B. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 2005;106:1021–30.

    Article  PubMed  CAS  Google Scholar 

  7. Schwaller J, Schneider P, Mhawech-Fauceglia P, McKee T, Myit S, Matthes T, Tschopp J, Donze O, Legal FA, Huard B. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B cell Lymphoma aggressiveness. Blood 2007;109:331–8.

    Google Scholar 

  8. Lopez-Fraga M, Fernandez R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2001;2:945–51.

    Article  PubMed  CAS  Google Scholar 

  9. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001;293:2111–4.

    Article  PubMed  CAS  Google Scholar 

  10. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 2001;15:289–302.

    Article  PubMed  CAS  Google Scholar 

  11. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004;101:3903–8.

    Article  PubMed  CAS  Google Scholar 

  12. von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 1997;278:138–41.

    Article  Google Scholar 

  13. von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity 2001;14:573–82.

    Article  Google Scholar 

  14. Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T, Tumas D, Grewal IS, Dixit VM. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2001;2:638–43.

    Article  PubMed  CAS  Google Scholar 

  15. Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 2003;18:279–88.

    Article  PubMed  CAS  Google Scholar 

  16. Hymowitz S, Patel D, Wallweber H, Runyon S, Yan M, Yin J, Shriver S, Gordon N, Pan B, Skelton N, Kelley R, Starovasnik M. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 2005;280:7218–27.

    Article  PubMed  CAS  Google Scholar 

  17. Ni C, Oganesyan G, Welsh K, Zhu X, Reed J, Satterthwait A, Cheng G, Ely K. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 2004;173:7394–400.

    PubMed  CAS  Google Scholar 

  18. Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe SRE, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 2000;192:137–43.

    Article  PubMed  CAS  Google Scholar 

  19. Jabara H, Laouini D, Tsitsikov E, Mizoguchi E, Bhan A, Castigli E, Dedeoglu F, Pivniouk V, Brodeur S, Geha R. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 2002;17:265–76.

    Article  PubMed  CAS  Google Scholar 

  20. Jabara HH, Geha RS. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J Allergy Clin Immunol 2005;115:856–63.

    Article  PubMed  CAS  Google Scholar 

  21. Ahonen C, Manning E, Erickson L, O’Connor B, Lind E, Pullen S, Kehry M, Noelle R. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 2002;3:451–56.

    Article  PubMed  CAS  Google Scholar 

  22. von Bulow GU, Russell H, Copeland NG, Gilbert DJ, Jenkins NA, Bram RJ. Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mamm Genome 2000;11:628–32.

    Article  Google Scholar 

  23. Zhang X, Park C, Yoon S, Li L, Hsu Y, Ambrose C, Choi Y. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 2005;17:779–88.

    Article  PubMed  CAS  Google Scholar 

  24. O’Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004;199:91–8.

    Article  PubMed  CAS  Google Scholar 

  25. Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005;201:35–9.

    Article  PubMed  CAS  Google Scholar 

  26. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004;173:2245–52.

    PubMed  CAS  Google Scholar 

  27. Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004;173:2331–41.

    PubMed  CAS  Google Scholar 

  28. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003;3:721–32.

    Article  PubMed  CAS  Google Scholar 

  29. He B, Qiao X, Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004;173:4479–91.

    PubMed  CAS  Google Scholar 

  30. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002;3:822–9.

    Article  PubMed  CAS  Google Scholar 

  31. Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 2004;3:211–7.

    Article  PubMed  CAS  Google Scholar 

  32. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004;76:707–26.

    PubMed  Google Scholar 

  33. Schroeder HW Jr., Schroeder HW III, Sheikh SM. The complex genetics of common variable immunodeficiency. J Investig Med 2004;52:90–103.

    PubMed  CAS  Google Scholar 

  34. Burrows PD, Cooper MD. IgA deficiency. Adv Immunol 1997;65:245–76.

    Article  PubMed  CAS  Google Scholar 

  35. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001;21:303–9.

    Article  PubMed  CAS  Google Scholar 

  36. Weston SA, Prasad ML, Mullighan CG, Chapel H, Benson EM. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin Exp Immunol 2001;124:465–9.

    Article  PubMed  CAS  Google Scholar 

  37. Eastwood D, Gilmour KC, Nistala K, Meaney C, Chapel H, Sherrell Z, Webster AD, Davies EG, Jones A, Gaspar HB. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 2004;137:584–8.

    Article  PubMed  CAS  Google Scholar 

  38. Farrington M, Grosmaire L, Nonoyama S, Fischer S, Hollenbaugh D, Ledbetter J, Noelle R, Aruffo A, Ochs H. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994;91:1099–103.

    Article  PubMed  CAS  Google Scholar 

  39. Warnatz K, Bossaller L, Salzer U, Skrabl-Baumgartner A, Schwinger W, van der Burg M, van Dongen JJ, Orlowska-Volk M, Knoth R, Durandy A, Draeger R, Schlesier M, Peter HH, Grimbacher B. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006;107:3045–52.

    Google Scholar 

  40. Kralovicova J, Kusikova M, Buc M, Holomanova D, Sakalova A. [Frequency of HLA-A, HLA-B and HLA-Cw antigens in the Slovak population]. Bratisl Lek Listy 2000;101:24–7.

    PubMed  CAS  Google Scholar 

  41. Islam KB, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith CI. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol 1994;152:1442–52.

    PubMed  CAS  Google Scholar 

  42. Wang Z, Yunis D, Irigoyen M, Kitchens B, Bottaro A, Alt FW, Alper CA. Discordance between IgA switching at the DNA level and IgA expression at the mRNA level in IgA-deficient patients. Clin Immunol 1999;91:263–70.

    Article  PubMed  CAS  Google Scholar 

  43. Asano T, Kaneko H, Terada T, Kasahara Y, Fukao T, Kasahara K, Kondo N. Molecular analysis of B-cell differentiation in selective or partial IgA deficiency. Clin Exp Immunol 2004;136:284–90.

    Article  PubMed  CAS  Google Scholar 

  44. Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI. TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 1991;3:1099–106.

    Article  PubMed  CAS  Google Scholar 

  45. Bonhomme D, Hammarstrom L, Webster D, Chapel H, Hermine O, Le Deist F, Lepage E, Romeo PH, Levy Y. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 2000;165:4725–30.

    PubMed  CAS  Google Scholar 

  46. Levy Y, Gupta N, Le Deist F, Garcia C, Fischer A, Weill JC, Reynaud CA. Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc Natl Acad Sci USA 1998;95:13135–40.

    Article  PubMed  CAS  Google Scholar 

  47. Andersen P, Permin H, Andersen V, Schejbel L, Garred P, Svejgaard A, Barington T. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 2005;105:511–7.

    Article  PubMed  CAS  Google Scholar 

  48. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha R. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005;37:829–34.

    Article  PubMed  CAS  Google Scholar 

  49. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005;37:820–8.

    Article  PubMed  CAS  Google Scholar 

  50. Reyes-Moreno C, Girouard J, Lapointe R, Darveau A, Mourad W. CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem 2004;279:7799–806.

    Article  PubMed  CAS  Google Scholar 

  51. Siegel R, Frederiksen J, Zacharias D, Chan F, Johnson M, Lynch D, Tsien R, Lenardo M. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 2000;288:2328–9.

    Article  Google Scholar 

  52. Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin, yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2005;5:496–503.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunology, Children’s Hospital, Department of Pediatrics, Harvard Medical School, One Blackfan Circle, Boston, MA, 02115, USA

    Emanuela Castigli & Raif S. Geha

Authors
  1. Emanuela Castigli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raif S. Geha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuela Castigli.

Additional information

Presented at the First Robert A Good Society Symposium, St. Petersburg, FL, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castigli, E., Geha, R.S. TACI, isotype switching, CVID and IgAD. Immunol Res 38, 102–111 (2007). https://doi.org/10.1007/s12026-007-8000-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-007-8000-2

Keywords

Search

Navigation